Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Capital Leases (2018 - 2024)

Solid Biosciences' Capital Leases history spans 7 years, with the latest figure at $307000.0 for Q3 2024.

  • For Q3 2024, Capital Leases fell 77.46% year-over-year to $307000.0; the TTM value through Sep 2024 reached $307000.0, down 77.46%, while the annual FY2023 figure was $1.2 million, 27.54% down from the prior year.
  • Capital Leases for Q3 2024 was $307000.0 at Solid Biosciences, down from $953000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $1.7 million in Q4 2022 and bottomed at $231000.0 in Q1 2022.
  • The 5-year median for Capital Leases is $632000.0 (2020), against an average of $818470.6.
  • The largest annual shift saw Capital Leases skyrocketed 590.91% in 2023 before it plummeted 77.46% in 2024.
  • A 5-year view of Capital Leases shows it stood at $525000.0 in 2020, then plummeted by 44.19% to $293000.0 in 2021, then surged by 481.23% to $1.7 million in 2022, then decreased by 27.54% to $1.2 million in 2023, then crashed by 75.12% to $307000.0 in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Capital Leases are $307000.0 (Q3 2024), $953000.0 (Q2 2024), and $1.1 million (Q1 2024).